Tirzepatide

Tirzepatide is a synthetic dual GLP-1 and GIP receptor agonist peptide. It is a 39-amino acid linear peptide that mimics the actions of both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). It is widely researched for its potent effects on metabolic regulation, glucose control, and weight management.

Key Features:

•  Purity: ≥99% (HPLC verified)

•  Form: Lyophilized white powder

•  Vial Size: Commonly 5mg, 10mg, or 15mg per vial

•  Sequence: Synthetic 39-amino acid peptide

Research Areas:

•  Blood glucose regulation and insulin sensitivity

•  Significant body weight reduction and appetite suppression

•  Metabolic syndrome and obesity studies

•  Cardiovascular health research

•  Type 2 diabetes management models

•  Long-acting incretin mimetic studies

Intended Use: For laboratory research and educational purposes only. Not for human consumption, diagnostic, or therapeutic use.

This high-quality research peptide is supplied in sterile, sealed glass vials with secure rubber stoppers and aluminum flip-off caps for safe reconstitution and storage.